Bio-techne Corporation (NASDAQ:TECH)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.


Player Avatar Doughboy33 (< 20) Submitted: 2/3/2009 8:13:53 PM : Outperform Start Price: $51.94 TECH Score: -22.65

Great business, slowing growth partly currency based and likely temporary. 2% yield, no debt, cash rich, buying back stock.

Featured Broker Partners